不育症患者睾丸曲细精管界膜的病理学观察

来源 :中国男科学杂志 | 被引量 : 0次 | 上传用户:worthylifelv
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
应用形态计量学和免疫组织化学方法观察 41例少精子症和无精子症患者的睾丸活检曲细精管界膜的病理学变化。曲细精管生精上皮的病理变化主要有三种类型 :生精功能低下、生精阻滞和唯支持细胞综合征。三种病变的曲细精管均表现有不同程度的界膜增厚。形态计量学结果显示三种病变的曲细精管界膜厚度、管内径与正常对照相比均有显著性差异 ,管内径与界膜厚度呈负相关。免疫组化层粘连蛋白及Ⅳ型胶原染色显示界膜的内外层呈阳性反应 ,而中间增厚带为阴性 ,Ⅰ型、Ⅲ型胶原免疫组化染色界膜增厚的中间带为阳性。提示 :病变界膜的成分为胶原纤维 ,但与正常成分———Ⅳ型胶原不同 ,表现为Ⅰ型及Ⅲ型胶原增生 The histopathological changes of testicular biopsies in 41 patients with oligospermia and azoospermia were observed by morphometry and immunohistochemistry. Tracheal seminiferous epithelium of the pathological changes are mainly three types: dysfunctional spermatogenesis, spermatogenic arrest and only support cell syndrome. Three kinds of lesions of seminiferous tubules showed varying degrees of membrane thickening. Morphometry results showed that the three kinds of lesions of the seminiferous tubule thickness, tube diameter compared with the normal control were significantly different, the tube diameter and the boundary membrane thickness was negatively correlated. Immunohistochemistry of laminin and type Ⅳ collagen staining showed that the inner and outer layers of the membrane showed a positive reaction, while the middle thickening zone was negative. The type Ⅰ and type Ⅲ collagen immunohistochemical staining showed that the medial zone was thicker. Tip: Lesions of the membrane components of collagen fibers, but with the normal component - type Ⅳ collagen, the performance of type Ⅰ and type Ⅲ collagen hyperplasia
其他文献
为探讨DAZ基因在男性生精过程中的作用及DAZ基因与男性不育症的关系。本文应用多重聚合酶链反应对男性不育症患者DAZ基因进行检测。并结合临床表型进行分析。结果在正常有生
患者 ,男 ,4 5岁。因右侧斜疝行巴西氏法疝修补术 ,高位结扎疝囊以后 ,游离精索 ,加强后壁 ,再于精索前缝合腹外斜肌腱膜。术后右侧阴囊水肿 ,睾丸胀疼 ,经平卧休息 ,硫酸镁
期刊
Objective: In view of the extensive bone damage in rheumatoid arthritis, we used a commonly utilized animal model to detect behavioral changes in pain-related a
为了探讨碱性成纤维细胞生长因子 (bFGF)对特发性少弱精子症患者的作用 ,本研究对 5 7例确诊为特发性少弱精子症的患者用bFGF治疗 ,分别在治疗前后进行血生殖激素测定和精液
结直肠癌(CRC)是世界范围内癌症发病与致死的主要因素,近几年分子靶向治疗的临床应用为晚期结直肠癌治疗带来了曙光.贝伐珠单抗被批准应用于一线和二线晚期结直肠癌的治疗,促